Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
private placement
Biotech
Oruka spins out of Paragon with assets, public listing and cash
Oruka Therapeutics is jumping onto the biotech stage with a bang, going public via reverse merger with a $275 million private placement.
Max Bayer
Apr 3, 2024 7:30am
Avrobio's corporate tremor attracts Tectonic for reverse merger
Jan 30, 2024 3:24pm
BridgeBio bags $250M in stock sale before acoramidis submission
Sep 25, 2023 11:20am
SpringWorks enjoys double payday from GSK deal, $225M funding
Sep 7, 2022 10:49am
Provention snags $60M to prep for diabetes drug launch
Jul 8, 2022 10:52am
Biophytis raises $12M for trials of aging disease duo
Oct 11, 2017 9:45am
